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Abstract 
The cannabinoid type 1 (CB1) receptor and the capsaicin receptor (TRPV1) exhibit 
co-expression and complex, but largely unknown, functional interactions in a sub-
population of primary sensory neurons (PSN). We report that PSN co-expressing CB1 
receptor and TRPV1 form two distinct sub-populations based on their 
pharmacological properties, which could be due to the distribution pattern of the two 
receptors. Pharmacologically, neurons respond either only to capsaicin (COR 
neurons) or to both capsaicin and the endogenous TRPV1 and CB1 receptor ligand 
anandamide (ACR neurons). Blocking or deleting the CB1 receptor only reduces both 
anandamide- and capsaicin-evoked responses in ACR neurons. Deleting the CB1 
receptor also reduces the proportion of ACR neurons without any effect on the overall 
number of capsaicin-responding cells. Regarding the distribution pattern of the two 
receptors, neurons express CB1 and TRPV1 receptors either isolated in low densities 
or in close proximity with medium/high densities. We suggest that spatial distribution 
of the CB1 receptor and TRPV1 contributes to the complexity of their functional 
interaction. 
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Introduction 
The capsaicin receptor, transient receptor potential cation channel, subfamily V, 
member 1 (TRPV1) is a non-selective cationic channel1.  In addition to a series of 
exogenous molecules including capsaicin the pungent agent of chilli papers, TRPV1 
is also directly activated, among other endogenous agents, by N-
arachidonoylethanolamine (anandamide)2,3,4. Anandamide is also an endogenous 
ligand for the G protein-coupled cannabinoid (CB) type 1 receptor2.  
 
Nociceptive primary sensory neurons (PSN) constitute the prototypical cell type, 
which expresses TRPV11,5. Activation of TRPV1 results in cationic influx, 
subsequent depolarisation and action potential generation1,4. The CB1 receptor, 
reduces neuronal excitability6,7 through the activation of the G protein-coupled 
inwardly rectifying K+ channel and the inhibition of adenylyl cyclase and high 
voltage-activated Cav1.2, Cav2.1, and Cav2.2 Ca2+ channels conducting L-type, P/Q-
type, and N-type currents, respectively8,9,10. CB1 receptor activation may also increase 
neuronal excitation through coupling to Gs or Gq/11, and the activation of adenylyl 
cyclase, phosphatidylinositol-3 kinase, and the mitogen-activated kinases, 
extracellular signal-regulated kinase 1 and 2, and p388,9,10. 
 
The CB1 receptor and TRPV1 exhibit co-expression in various neurons including a 
major sub-population of PSN in dorsal root ganglia (DRG11,12,13 but see14,15). The 
anatomical arrangement between these two receptors allows a complex, but currently 
largely unknown, crosstalk that involves activation of both TRPV1 and the CB1 
receptor by anandamide.  
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In order to better understand how the CB1 – TRPV1 crosstalk shapes neuronal 
excitability, we herein investigated the functional interaction between the receptors, 
with particular attention to their spatial distribution in PSN and the effect of 
anandamide.  
 
Results 
Anandamide applied for 20 seconds at a concentration range (1μM, 3μM, 10μM and 
30μM) known to induce excitation3,16 of cultured rat PSN, produced concentration-
dependent inward currents at -60mV membrane potential with an EC50 of 2.2μM 
(Figure 1A and B; Supplementary Table 1). The excitatory effect of anandamide was 
washed off within a few tens of seconds after stopping anandamide application 
(Figure 1A and C). Anandamide at 30μM reached its maximal excitatory effect 
(Figure 1B).  
 
All the anandamide-responding neurons that were tested for capsaicin-responsiveness 
(Supplementary Table 2) produced currents to capsaicin applied at around its EC50 
value (500nM1,4), 2 minutes after anandamide superfusion (n=29; Figure 1C and D). 
However, a sub-population of neurons, while not responding to anandamide 
responded only to capsaicin (n=10; Figure 1E and F; Table 1 and Supplementary 
Table 2). Hence, anandamide- and capsaicin-responsiveness defined two sub-
populations of PSN: the “anandamide-and-capsaicin-responsive“ (ACR) and the 
“capsaicin-only-responsive” (COR) neurons (Figure 1C-F).  
 
The proportion of COR neurons in the overall sample of capsaicin-responsive cells 
was 25.6% (10 of the 39 cells; Table 1; Supplementary Table 2) and independent of 
  5 
 
anandamide concentration up to 30μM (Supplementary Table 2; p= between 1 and 
0.6, Fisher’s exact test). The concentration of anandamide, applied before capsaicin 
application, did not have significant effect on the amplitude of capsaicin-evoked 
responses in ACR or COR neurons (data not shown; p= between 0.98 and 0.11, 
ANOVA). Therefore, we pooled the amplitudes of capsaicin-evoked responses in 
ACR and COR neurons, respectively. The pooled capsaicin-evoked amplitudes were 
significantly different (ACR: -3.19±0.31nA, n=29; COR: -0.96±0.27nA, n=10; 
p=0.002, Student’s t-test).  
 
Since the anandamide concentration had no effect on either the proportion of 
responsive cells or the response to subsequent capsaicin application, we used 
anandamide at 30μM in the rest of the experiments.  
 
TRPV1 is highly permeable to Ca2+ 1,4. Therefore, to confirm the presence of ACR 
and COR neurons, we studied changes in the intracellular Ca2+ concentration ([Ca2+]i) 
by anandamide (30μM) and capsaicin (500nM) in rat cultured PSN grown for 16-22 
hours.  
 
Of the 98 KCl-responding neurons, 57 responded to capsaicin. Only 40 of the 
capsaicin-responsive neurons responded also to anandamide (Supplementary Figure 
1). The ACR:COR neuron ratio was not significantly different from that found using 
whole-cell recordings (Table 1). The amplitude of the capsaicin-evoked calcium 
transients was significantly greater in ACR than in COR neurons (1.01±0.12 in ACR 
(n=40) and 0.49±0.13 (n=17); Supplementary Figure 1; p=0.015, Student’s t-test). 
The TRPV1 antagonist capsazepine (10μM) blocked the anandamide-evoked Ca2+ 
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transients indicating that the anandamide-evoked excitatory effect is indeed mediated 
through TRPV1 in PSN (Supplementary Figure 2).   
 
Next we assessed 30 μM anandamide- and 500 nM capsaicin-evoked changes in 
[Ca2+]i in PSN cultures prepared from WT-TRPV1 and TRPV1-/- mouse DRG (Figure 
1G-I) to determine whether ACR and COR neurons are also present in another species 
and the excitatory effects by both anandamide and capsaicin are indeed mediated 
exclusively through TRPV1. To verify chemosensitivity of PSN isolated from 
TRPV1-/- mice, we also administered mustard oil (50 μM) following capsaicin 
application to the cells.  
 
Responses of 136 KCl-responding WT-TRPV1 cells were analysed. Of these, 54 
neurons responded to capsaicin, of which 37 were ACR and 17 were COR neurons 
(Figure 1G and H; Table 1). The ACR:COR ratio was not significantly different from 
that found with whole-cell recordings or Ca2+ imaging from rat cultured PSN (Table 
1). The increase in [Ca2+]i induced by capsaicin was significantly smaller in COR 
neurons than in ACR cells (ACR: 2.09±0.13 (n=37); COR: 0.81±0.17 (n=17); 
p<0.0001, Student’s t-test).  
 
Neither anandamide nor capsaicin increased the [Ca2+]i in the 126 TRPV1-/- neurons 
we assessed (Figure 1I). However, 36 of the 126 neurons responded to mustard oil 
indicating that in general, chemosensitivity of the neurons remained intact (Figure 1I).  
 
These data show that anandamide- and capsaicin-responsiveness are partially 
segregated in rodent PSN. Although we cannot categorically exclude the possibility 
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that compensatory changes in TRPV1-/- mice contribute to the lack of anandamide 
responsiveness, we suggest that both the anandamide- and capsaicin-evoked 
excitation depend on TRPV1 in PSN. Considering that TRPV1 mediates the 
excitatory effect of both capsaicin and anandamide, the behaviour of ACR and COR 
neurons is underlain by differential responsiveness of TRPV1 to these agents in the 
two types of neurons.  
 
The two main sub-populations of nociceptive PSN, the peptidergic and Bandeiraea 
simplicifolia lectin (IB4)-binding cells,17 exhibit different capsaicin-evoked 
responses18,19. However, our data indicate that the presence or absence of 
neuropeptides do not contribute to the partial segregation of anandamide- and 
capsaicin-responsiveness in PSN (Supplementary Table 3).  
 
The CB1 receptor is able to regulate TRPV1 responsiveness 20,16,21-23,24,25,26,27. Further, 
rimonabant at less than ~200nM is a selective and specific CB1 receptor 
antagonist/inverse agonist28,29. Therefore, we used 200nM rimonabant to determine 
whether the CB1 receptor contributes to the segregation of responses.  
 
First we used whole-cell voltage-clamp recordings from cultured rat PSN to facilitate 
comparison with data obtained in the first experiment (Table 1). Rimonabant, which 
was continuously superfused, did not change the ACR:COR neuron ratio (Figure 2A; 
Table 1). However, interpretation of this finding requires caution due to the relatively 
low number of neurons. Nevertheless, the amplitude of 30 μM anandamide-evoked 
currents was significantly reduced from -1.07±0.33nA (n=7) to -0.59±0.18nA (n=11; 
Figure 2B; p=0.006, Student’s t-test; Supplementary Table 2) with rimonabant. 
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Rimonabant significantly reduced the amplitude of the capsaicin-evoked responses in 
ACR neurons (from -3.19±0.31nA (n=29) to -1.82±0.40nA (n=11); p<0.001, 
Student’s t-test) but not in COR neurons (-0.96±0.27nA (n=10) to -0.54±0.31nA 
(n=7), p=0.34, Student’s t-test; Figure 2C). Because of the high variability of data on 
COR neurons, interpretation requires caution. Nevertheless, these findings did suggest 
that the CB1 receptor might have a sensitising effect on capsaicin-evoked responses in 
ACR neurons, which might not be present in COR neurons. Subsequently, we 
conducted experiments to confirm the CB1-mediated sensitising effect on TRPV1 and 
to study the underlying mechanisms.   
 
First, to confirm the role of the CB1 receptor in sensitising TRPV1 in ACR neurons, 
we isolated PSN from Biozzi ABH (WT-CB1) and Biozzi ABH mice lacking the CB1 
receptor (CB1-/-). We have chosen these mice, because they exhibit a significantly 
altered endocannabinoid system in comparison to C57BL/6 mice, and we used Biozzi 
ABH mice in previous studies30. Due to the significantly altered endocannabinoid 
system, we expected to find differences in TRPV1-mediated responses in C57BL/6 
(background for TRPV1-/- mice) and Biozzi ABH mice if our hypothesis on the 
sensitising effect of the CB1 receptor on TRPV1 were correct. To increase the 
efficacy of sampling, we again assessed changes in the [Ca2+]i.  
 
Anandamide increased the [Ca2+]i in 113 of 230 KCl-responding neurons of WT-CB1 
mice, all of which responded to capsaicin (Figure 3A). In addition to the 113 ACR 
neurons, 11 of the 230 neurons exhibited responses only to capsaicin (Figure 3A). The 
ACR:COR neuron ratio was significantly higher in WT-CB1 mice than in WT-
TRPV1 mice or rats (Table 1). These data supports our view that the cannabinoid 
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system contributes to regulating TRPV1 responsiveness. To get direct evidence for 
the involvement of the CB1 receptor, we next measured responses in PSN cultures 
prepared from CB1-/- mice.  
 
The proportion of neurons responding to anandamide was significantly reduced within 
the total number of capsaicin-responding cells in CB1-/- mice (Figure 3A; Table 1). At 
the same time, the proportion of COR neurons within the total number of capsaicin-
responding neurons was significantly increased (Figure 3A; Table 1). However, the 
overall proportion of neurons responding to 500nM capsaicin in CB1-/- mice (115 of 
200) was not statistically different to that in WT-CB1 mice (124 of 230, p=0.56, 
Fischer’s exact test).  
 
Deleting the CB1 receptor significantly reduced the amplitude of both anandamide 
(from 0.42±0.03, n=113, to 0.30±0.03, n=74, p=0.02, Student’s t-test; Figure 3B) and 
capsaicin-evoked responses (from 0.56±0.06, n=113, to 0.39±0.04, n=74, p=0.01, 
Student’s t-test; Figure 3C) in ACR neurons. However, there was no significant 
difference in the amplitude of capsaicin-evoked responses between COR neurons 
isolated from WT-CB1 and CB1-/- mice (from 0.45±0.11, n=11, to 0.38±0.04, n=41, 
p=0.42, Student’s t-test; Figure 3C). These findings confirm that the CB1 receptor 
executes a sensitising effect on TRPV1, which increases capsaicin- and anandamide-
evoked responses in ACR neurons. Further, these findings also indicate that in 
addition to sensitising TRPV1, the CB1 receptor also contributes to the partial 
segregation of anandamide- and capsaicin-responsiveness in PSN.  
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CB1 receptor activity can be evoked by endogenous ligands, such as anandamide, 
synthesised by a major proportion of TRPV1-expressing (hence CB1 receptor-
expressing11,12) PSN31,32,33,27. Alternatively, the CB1 receptor-mediated effects could 
be due to its constitutive activity28,34. To differentiate between these mechanisms, we 
next compared the effects on capsaicin-evoked responses of rimonabant, which blocks 
both evoked and constitutive activity, and NESS032735, which only inhibits ligand 
binding. To exclude the possibility of CB1 receptor activation by exogenous 
anandamide, capsaicin application was not preceded by anandamide superfusion. We 
assessed changes in the [Ca2+]i to increase efficacy and we applied 100nM capsaicin 
to diminish TRPV1 desensitisation36. 
 
Capsaicin was applied 3 times consecutively with 2 minutes intervals to identify 
capsaicin responsive cells. The further application of 30μM anandamide revealed 161 
ACR and 36 COR neurons in rat cultured PSN (Figure 4; Table 1). This ratio was not 
significantly different from our previous findings with either whole-cell recordings or 
Ca2+ imaging from cultured rat PSN (Table 1). The average amplitudes of the first 
capsaicin-evoked responses in ACR neurons (1.07±0.05, n=161) was significantly 
greater than that in COR neurons (0.51±0.07, n=36; p<0.0001, Student’s t-test; Figure 
4C and F).  
 
100nM capsaicin induced desensitisation in both ACR and COR neurons (Figure 4A, 
C, D and F). Interestingly, the desensitisation was significantly greater in COR than in 
ACR neurons (Figure 4A, C, D and F).  
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While rimonabant, applied immediately after the first capsaicin application until the 
end of the second capsaicin application (Figure 4B and E), did not have any effect on 
the [Ca2+]i per se, it significantly increased the rate of reduction in the average 
amplitude of the second capsaicin-evoked responses in ACR (Figure 4B and C; 
p=0.0001, Student’s t-test) but not in COR neurons (Figure 4E and F; p=0.62, 
Student’s t-test). Although, several ACR neurons exhibited partial recovery in their 
capsaicin-evoked responses after stopping rimonabant application (Figure 4B), the 
rate of reduction in the average amplitude of the third capsaicin-evoked responses in 
these cells was still significantly greater when compared to that of the control 
experiment (Figure 4C; p<0.0001, Student’s t-test). No such differences were seen in 
COR neurons (Figure 4F, p=0.084; Student’s t-test). Notably, in addition to reducing 
the amplitude of the capsaicin-evoked responses in ACR cells, rimonabant also 
prolonged the recovery of responses in a group of both types of neurons 
(Supplementary Figure 3).  
 
In contrast to rimonabant, NESS0327 at 100nM per se substantially enhanced the 
duration of the capsaicin-evoked Ca2+ transients (Supplementary Figure 4A and B). 
This increase did not allow further assessment in the great majority of cells 
(Supplementary Figure 4A and B). The [Ca2+]i-increasing effect was less pronounced 
at 1nM, and when NESS0327 was applied 30 seconds after stopping capsaicin 
application an apparently capsaicin-independent increase in the [Ca2+]i was produced 
(Supplementary Figure 4C). In this condition, 1nM NESS0327 did not produce any 
effect on the amplitude of the second capsaicin application-evoked responses in COR 
neurons (n=9; p=0.74, Student’s t-test), whereas an increase was apparent in ACR 
neurons (n=25; control: 94.66±1.74% of the first response; NESS0327: 
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116.76±9.52% of the first response; p=0.0002, Student’s t-test; Supplementary Figure 
4D-E). Although the excitatory effect of NESS0327 on PSN, the elucidation of which 
was not in the scope of the present study, makes interpretation of these findings very 
difficult, the lack of inhibitory effect may suggest that ligand-induced activation of 
the CB1 receptor does not contribute to TRPV1 sensitisation in PSN.  
 
The finding that CB1 receptor inhibition or deletion has no effect on COR neurons 
may suggest that COR neurons might not express the CB1 receptor. To test this 
hypothesis, we next studied CB1 receptor expression in PSN by single-cell reverse 
transcription polymerase chain reaction (RT-PCR).    
 
We collected 25 COR, 31 ACR and 20 cells, which did not respond to either of the 
TRPV1 activators (NR) from rat PSN cultures. The ACR:COR neuron ratio was not 
significantly different from the observation we made in whole-cell recordings from 
cultured rat PSN (Table 1). The amplitude of capsaicin-evoked responses was 
significantly larger (p<0.0001, Student’s t-test) in ACR (-3.28±0.35nA, n=31) than in 
COR (-0.67±0.06nA, n=25) neurons. RNA of 10 COR, 11 ACR and 8 NR cells were 
processed successfully with single-cell RT-PCR (i.e. the sample showed GAPDH 
mRNA expression; Figure 5A and B).  
 
CB1 receptor primers produced amplicons of the predicted size, whereas no 
amplicons were present when no template was included in the PCR mixture  (Figure 
5A; Supplementary Figure 5). All ACR neurons (n=11), eight of ten COR neurons, 
and four of eight NR neurons exhibited detectable CB1 receptor mRNA expression 
(Figure 5B). Immunolabelling of cultured rat PSN using an anti-CB1 receptor and 
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anti-TRPV1 antibody confirmed the high proportion of TRPV1-expressing cells also 
expressing the CB1 receptor (149 of 150, Table 1; Supplementary Figure 6).  
 
For the control of immunostaining and assessing possible differences between the 
intact DRG and cultured PSN, we also established the co-expression ratio of TRPV1 
and the CB1 receptor in the intact DRG (Supplementary Figure 7 and 8). We found a 
slightly smaller proportion of TRPV1-expressing cells exhibiting obvious 
immunopositivity for the CB1 receptor in intact DRG than in PSN cultures 
(88.3±3.8%, n=3). This small difference could be due to culturing. Nevertheless, 
together, these findings indicate that the differing effects of rimonabant or deleting the 
CB1 receptor in ACR and COR neurons cannot be due to the exclusive expression of 
the CB1 receptor in ACR type neurons. Therefore, next we assessed the spatial 
distribution pattern of the CB1 receptor and TRPV1. 
 
Immunocytochemistry on SDS-digested freeze-fracture replicas (SDS-FRL) is a 
highly effective method to reveal sub-cellular protein distribution37. TRPV1-labelling, 
which served as a basis for selection of putative somatic membranes of PSN, was 
generally moderate to strong (Figure 6A and B). All TRPV1-expressing membranes 
we examined exhibited immunolabelling for the CB1 receptor, which was also 
moderate to strong in general. Both TRPV1 and CB1 receptor immunoreactivities 
were specifically detected on the protoplasmic face (Figure 6A and B). Virtually no 
labelling was observed on the exoplasmic face (Figure 6A and B), which is in 
agreement with the epitope of both the anti-TRPV1- and anti-CB1 receptor antibodies 
raised against intracellular part of the respective molecules (see Material and 
Methods).  
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Membrane patches co-expressing TRPV1 and CB1 receptors differed in receptor 
densities and distribution (Figure 6A and B). Some of the patches exhibited only a 
few isolated receptors (Figure 6A). The majority of the membrane patches however 
exhibited a relatively high density of CB1 receptor expression, which was 
accompanied by moderate to high TRPV1 receptor density (Figure 6B). It is unlikely 
that the differences in densities could be due to major regional variation of receptor 
distribution within a single cell, because no such differences were evident by visual 
assessment of about 100 TRPV1 and CB1 receptor co-expressing cultured PSN 
neurons or PSN in intact DRG (Supplementary Figure 6 and Supplementary Figure 
8). 
 
We found that two, three or sometimes four immunoparticles labelling TRPV1 in 
these membranes often formed clusters (Figure 6B). The distance of the gold particles 
in these clusters was between ~10 and ~55nm (Figure 6B). Although the majority of 
the CB1 receptors appeared solitary, some of them seemed to be in close vicinity 
(<~55nm) to TRPV1 (Figure 6B).  
 
We established morphometric data of 21 membrane patches (Table 2), which had an 
average size of 5.20±0.39μm2 and exhibited 2788 gold particles of which 1793 
(85.38±16.03, n=21, on average) and 995 (47.38±6.78, n=21, on average) labelled 
CB1 receptor and TRPV1, respectively. The densities for both receptors varied in a 
wide range (Table 2) and the CB1 receptor density was significantly higher than that 
of TRPV1 (p=0.024, Student’s t-test). Correlations between some properties are 
shown in Supplementary Figure 9.  
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We also established the number of distances measured between each TRPV1 and its 
closest CB1 receptor neighbour as well as between each CB1 receptor and its closest 
TRPV1 neighbour, which were below 54.5nm (Table 2). This threshold represents the 
maximum (“critical”) distance between the centres of the gold particles if the two 
receptors are positioned next to each other, and is based on the estimated size of the 
CB1 receptor, TRPV1, IgG and the gold particles38,39,40,41 (Table 2; Supplementary 
Figure 10A). The number of distances between each TRPV1 and the closest TRPV1 
neighbour shorter than 56nm, which represents the estimated maximum distance if 
TRPV1 molecules are located next to each other (Supplementary Figure 10B), was 
also established. The number of critical distances was then divided by the number the 
appropriate receptor in each patch.  
 
Principal component analysis (PCA), an unsupervised multivariate statistical tool, 
which reduces the number of variables and maximises the variability of data, 
suggested the presence of 2 major groups and 3 outliers (Supplementary Figure 11). 
PCA’s loading plot suggested that the number of CB1 receptor – TRPV1 critical 
distances does not contribute significantly to the variability of data (not shown). After 
removing the outliers and non-significant variables, PCA identified three principal 
components (PCs) that together contributed to more than 80% of the variability. The 
PCA score plot suggested the presence of 2-4 groups of cells (Supplementary Figure 
11).  
 
To study the putative groupings in more details, we built a partial least square 
discriminant analysis (PLS-DA) model, which again suggested the presence of 3 PCs 
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(Figure 7A). The PLS-DA score plot clearly showed the separation of three major 
groups (Figure 7B). The loading plot (Figure 7C) shows how, while the variable 
importance of projection plot (Figure 7D) reveals the significance of, the various 
morphometric properties contributed to the separation of neurons.  
 
Neurons in Groups 1 (yellow in Figure 7B) exhibited significantly smaller CB1 
receptor densities, larger TRPV1 – CB1 receptor average distances, and fewer TRPV1 
– CB1 receptor critical distances than neurons in Group 2 (red in Figure 7B) and 
Group 3 (purple in Figure 7B; Figure 7E and F; Table 2). Neurons in Group 2 were 
different from neurons in Group 3 mainly in TRPV1 distribution (Figure 7E and F; 
Table 2). Together these data indicate that the distribution of the CB1 receptor and 
TRPV1 enables an intensive crosstalk in a large proportion of PSN (Group 2 and 
Group 3 neurons) and, due to the large distances between the two receptors, a limited 
crosstalk in a small group of neurons (Group 1). Importantly, the proportion of Group 
1 – Group 2/Group 3 neurons was not significantly different from ACR – COR 
neuron proportion found in rat or C57BL/6 mice (Table 1).    
 
The presence of a significant proportion of CB1 receptors and TRPV1 closer than 
54.5nm to each other in PSN suggests that the two receptors, similarly to the cornea,26 
could be engaged in protein-protein interaction. Therefore we next performed 
immunoprecipitation by either an anti-TRPV1 or an anti-CB1 receptor antibody 
followed by immunoblotting respectively with an anti-CB1 receptor or anti-TRPV1 
antibody on protein samples isolated from rat DRG. We found in both experiments 
that the immunoprecipiated proteins contained the other molecule (Figure 8).      
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Discussion 
We applied a broad range of technologies to address the functional and structural 
interactions between the CB1 receptor and TRPV1 in PSN. As a major finding, we 
provide data indicating that spatial distribution of the CB1 receptor and TRPV1 is 
pivotal for the presence of two types of capsaicin sensitive PSN, the ACR and COR 
neurons, which are differentiated by their sensitivity to anandamide.  
 
Anandamide, in addition to TRPV1 and the CB1 receptor, also interacts with a series 
of other molecules42,10. These interactions could directly or indirectly induce cationic 
influx into sub-populations of PSN42,43,44. However, anandamide fails to increase the 
[Ca2+]i in PSN of TRPV1-/- mice, and the maximum 30 seconds application time we 
used is not enough for indirect anandamide-evoked activation42. Although we cannot 
exclude compensatory down-regulation of all anandamide-responsive proteins in 
TRPV1-/- mice, these findings strongly suggest that the excitatory effect of 
anandamide depends on TRPV1.  
 
Cultured PSN that respond to capsaicin but not to anandamide have been described 
previously as a “very small proportion” of neurons22. Here we provide unambiguous 
evidence of pharmacologically distinct COR and ACR phenotypes in capsaicin-
sensitive cultured PSN. We demonstrate that COR neurons constitute a significant 
proportion of cells, which does not depend on the length of culturing (at least between 
16 and 74 hours), the order of anandamide or capsaicin application or the 
concentration of anandamide. However the findings that Biozzi ABH mice, which 
exhibit a significantly altered endocannabinoid system30, possess a significantly lower 
ratio of COR neurons than Sprague-Dawley rats or CB57BL/6 mice, and that deleting 
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the CB1 receptor in Biozzi ABH mice reduces the proportion of ACR neurons, 
indicate that the ACR – COR ratio is affected by the endocannabinoid system.  
 
Importantly, CB1 receptor deletion does not reduce the overall proportion of neurons 
responding to capsaicin. This finding indicates that while capsaicin-sensitivity is an 
inherent, anandamide-sensitivity is an acquired property of native TRPV1. This 
behaviour of native TRPV1 is in stark contrast to heterologous TRPV1, which 
exhibits responsiveness both to capsaicin and anandamide without the CB1 receptor 
being expressed by the same cell3,45.  
 
In addition to reducing the proportion of ACR neurons, deleting the CB1 receptor also 
reduces the amplitude of capsaicin- and anandamide-evoked responses in ACR, but 
not in COR neurons. Rimonabant, which inhibits both constitutive and ligand-evoked 
CB1 receptor activation28,29, also reduces both anandamide- and capsaicin-evoked 
responses only in ACR neurons. However NESS0327, which blocks ligand-binding to 
the CB1 receptor,35 does not reduce responses in either cell types. Together these data, 
in agreement with recent findings,23 indicate that the CB1 receptor, through its 
constitutive activity, produces a sensitising effect on TRPV1 in a significant 
proportion of PNS.  
 
Considering the sensitising effect of the CB1 receptor on TRPV1, deleting the CB1 
receptor could reduce the number of ACR neurons through at least two mechanisms. 
First, due to the complete loss of the sensitising effect, anandamide-evoked responses 
could be reduced to below the detection threshold in a major proportion of ACR 
neurons. Alternatively, due to the loss of the protein-protein interaction, which is 
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indicated by the results of our immunoprecipitation experiment, conformational 
changes, which could promote anandamide-responsiveness, are lost.  
 
Deleting the CB1 receptor however, does not eliminate anandamide responsiveness. 
Therefore, mechanisms other than TRPV1 – CB1 crosstalk could also promote 
anandamide-responsiveness of TRPV1 in PSN. These may include TRPV1 
sensitisation/promotion of anandamide-responsiveness by other metabolic receptors, 
or differing composition of the TRPV1 ion channel. Indeed, while the TRPV1 ion 
channel is functional either as a homo- or heterotetramer40,39,46,47,48,49, and the SDS-
FRL immunolabelling is highly effective in revealing molecules37, we found the great 
majority of TRPV1 molecules to be in isolation in a group of neurons. However, 
analysis of morphometric data indicate that the number of TRPV1-TRPV1 critical 
distances might not play a major role in defining ACR or COR phenotype.  
 
Rimonabant increases the time-course of recovery when changes in the [Ca2+]i are 
used to assess responsiveness to capsaicin. However, no similar effect of rimonabant 
can be observed when responses are assessed by measuring whole-cell currents. 
Therefore, this rimonabant-evoked effect could be due to the reduced inhibitory effect 
of the CB1 receptor on voltage-gated Ca2+ channels8,9,10 rather than a reduced 
inhibitory effect on TRPV1.  
 
NESS0327 at 1nM increases the amplitude of capsaicin-evoked Ca2+ transients in 
ACR neurons, which may also suggest that an inhibitory effect is produced in these 
cells by CB1 receptor activity evoked, for example, by anandamide synthesised by 
sub-populations of PSN33,31,32,27. However, NESS0327 per se increases the [Ca2+]i in 
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capsaicin-responding cells. Therefore, in addition to reduced CB1 receptor-mediated 
inhibition of TRPV1, direct or indirect effects of Ca2+ permeable channels or blocking 
Ca2+ sequestration could also underlay this effect.  
 
The lack of a significant CB1 receptor-mediated inhibitory effect on TRPV1 is 
surprising because a series of reports confirms this effect20,16,21,22,24,25,26. However, the 
anandamide-induced and CB1 receptor-mediated inhibitory effect on TRPV1 is 
evident at low nM anandamide concentration16,24,25. Therefore, it is reasonable to 
assume that the downstream effects of anandamide on the CB1 receptor may depend 
on the concentration of this agent, and only the low nM anandamide-evoked CB1 
receptor signalling can overcome the constitutive activity-mediated sensitising effect.  
 
While our single-cell RT-PCR experiments show that all ACR and the majority of 
COR neurons express the CB1 receptor, the use of rimonabant or the deletion of the 
CB1 receptor reduces responses only in ACR neurons. Therefore, differing spatial 
distribution pattern of the two molecules could underlay different responses in the two 
types of neurons. Morphometric data indeed reveals the presence of three distinct 
distribution patterns of TRPV1 and CB1 receptors on membrane patches of PSN. 
Membrane patches belonging to two groups (Group 2 and Group 3; Figure 7B), which 
differ from each other mainly in the distribution of TRPV1, express the two receptors 
in medium/high density and proximity, whereas a smaller group of patches (Group 1; 
Figure 7B) expresses the receptors in low density and in isolation. This latter group is 
differentiated from the rest of the patches by its low CB1 receptor density and the low 
number or absence of TRPV1-CB1 receptor critical distances. Importantly, our 
functional studies also suggest that spatial proximity of TRPV1 and the CB1 receptor 
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could be responsible for the anandamide-responsiveness-promoting effects of the CB1 
receptor on TRPV1, explaining the presence of ACR and COR neurons. Further, the 
proportion between ACR and COR neurons and neurons expressing the receptors in 
high density and close proximity and in low density and isolation are statistically 
insignificant. Based on these considerations, it is reasonable to hypothesise that 
neurons expressing the two receptors in high density and close proximity could be 
associated with the ACR, whereas those expressing the two receptors in low density 
and in isolation could be COR in phenotype.  
 
In summary, our data demonstrate that the CB1 receptor sensitises TRPV1 and 
promotes anandamide-responsiveness of TRPV1 in a major sub-population of 
capsaicin-sensitive PSN, and that spatial proximity of the two molecules may 
underlay these effects. The sensitising and anandamide-responsiveness-promoting 
effects in PSN are of particular importance because TRPV1 in these neurons is pivotal 
in the development of pain in peripheral pathologies50,51, whereas activation of the 
CB1 receptor by anandamide in PSN has an analgesic effect52,53. Therefore, 
increasing anandamide levels through the inhibition of FAAH has been suggested as a 
novel means to control pain associated with peripheral pathologies53,54,55. Our present 
findings however, indicate that increased tissue levels of anandamide, which seems to 
have limited TRPV1 desensitising effect56, could significantly reduce the potential 
analgesic efficacy of FAAH inhibitors. Therefore, in order to utilise the analgesic 
potential of endogenous anandamide fully in PSN, ways to interfere with the 
mechanisms, through which the CB1 receptor promotes anandamide-responsiveness 
and sensitisation of TRPV1, must be identified. Due to the co-expression of TRPV1 
and the CB1 receptor in various areas of the brain13 , the CB1 receptor – TRPV1 
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crosstalk we characterised in the present study could also have relevance in brain 
signal processing.  
 
Methods 
All procedures were performed in accordance with the UK Animals (Scientific 
Procedures) Act 1986, the revised National Institutes of Health Guide for the Care 
and Use of Laboratory Animals, the Directive 2010/63/EU of the European 
Parliament and of the Council on the Protection of Animals Used for Scientific 
Purposes and the guidelines of the Committee for Research and Ethical Issues of 
IASP published in Pain, 16 (1983) 109-110. Further, we obeyed to Good Laboratory 
Practice and ARRIVE guidelines. All procedures on animals were approved by 
veterinary services (Central Biological Services) at Imperial College London, UK. 
Every effort was taken to minimize the number of animals used. 
 
Drugs 
The following drugs were used in this study: capsaicin (500nM or 100nM, Tocris, 
UK); anandamide (1nM to 30μM, Tocris), rimonabant (200nM, NIH, USA), mustard 
oil (50 μM; Sigma), NESS0327 (Cayman Chamicals) and ionomycin (5μM, Sigma). 
Anandamide was dissolved in ethanol then the stock solution was prepared with 
Tocrisolve (Tocris). Capsaicin, rimonabant, mustard oil, NESS0327 and ionomycin 
stock solutions were prepared in DMSO. The final DMSO dilution was equal or less 
than 1:2000. The minimum final Tocrisolve and ethanol dilutions were ~1:106 and 
1:500, respectively. In control experiments, none of the vehicles at their maximum 
concentration produced any responses (data not shown).  
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Animals 
Forty four male Sprague-Dawley rats (80-200g) and nine wild type (five C57BL/6 
x129SvJ (WT-TRPV1) and 4 Biozzi ABH (WT-CB1) and five TRPV1-/- and four 
CB1-/- mice (with C57BL/6 x129SvJ and Biozzi ABH background for TRPV1-/- and 
CB1-/-, respectively) were housed in climate-controlled rooms, on a 12 h light/dark 
cycle and with food and water ad libitum. All mice were male and between 20 and 
25g. Animals were terminally anaesthetised by isoflurane or CO2, and decapitated.  
 
Cell culturing 
Dorsal root ganglia from the C1 to the S1 segment were dissected and placed into 
Ham’s nutrient F12 culture medium (Sigma, UK) supplemented with 1mM L-
glutamine (Invitrogen, UK), 5000 IU/ml penicillin (Invitrogen, UK), 5000 μg/ml 
streptomycin (Invitrogen, UK) and 2% ultroser G (Biospectra, France). Ganglia were 
incubated in type IV collagenase (Lorne Diagnostics, UK, 300 U/ml) for 3 hours at 
37ºC at 5% CO2. Following several washes in the supplemented culture medium, 
ganglia were triturated with fire-polished Pasteur pipettes, and plated on poly-DL-
ornithine (Sigma, UK)-coated glass coverslips in the supplemented medium. Cells 
were grown in the supplemented medium in the presence of 50ng/ml nerve growth 
factor (NGF, Promega, USA) for16-72 hours.  
 
Electrophysiology 
Cells attached to coverslips were placed into a recording chamber and superfused with 
a bath solution (1-2ml/min). Borosilicate glass micropipets (4-6MΩ) were pulled on a 
DMZ automated electrode puller (DMZ, Germany). Conventional whole-cell voltage-
clamp recordings were done from neurons of 15-30μm in diameter using an Axopatch 
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200B amplifier, Digidata 1200 digitizer and the pClamp 8 software package 
(Molecular Devices, USA) with a respective sampling and filtering rate of 1kHz and 
5kHz at 37˚C. The holding potential was -60mV.  
 
The bath and pipette solutions contained (concentrations in mM) NaCl 150, KCl 5, 
MgCl2 2, CaCl2 2, HEPES 10, glucose 10, and NaCl 5, KCl 150, MgCl2 2, HEPES 
10, EDTA 1, respectively. The pH of both the bath and pipette solutions was adjusted 
to pH7.4. Drugs were applied in the bath solution through a small plastic tube (i.d. 
0.5mm) that was placed within ~100μm from the cell from which the recording was 
done. Drug application was controlled by the pClamp8 software package, and 
anandamide and capsaicin were applied two minutes apart. In some experiments 
neurons were incubated it fluorescein isothiocyanate -conjugated IB4 to identify one 
of the main sub-populations of nociceptive primary sensory neurons.  
 
Ca2+-imaging 
For assessing changes in the [Ca2+]i, primary sensory neurons cultured for 1-3 days 
were loaded with Fura-2 acetoxymethyl ester (Fura-2 AM, 5 μM; Molecular Probes, 
Inc., Eugene, OR) in the presence of 2 mM probenecid (Molecular Probes) for 60 
minutes at 37ºC in a HEPES-buffered saline (in mM): NaCl 122; KCl 3.3; CaCl2 1.3; 
MgSO4 0.4; KH2PO4 1.2; HEPES 25; glucose 10; adjusted with NaOH to pH 7.4. 
Coverslips were placed in a laminar flow perfusion chamber (Warner Instrument 
Corp., UK) and superfused with extracellular solution (in mM: NaCl 160; KCl 2.5; 
CaCl2 1; MgCl2 2; HEPES 10; glucose 10; pH 7.4) continuously via a six-channel 
perfusion system. The following test solutions were applied to the cells: anandamide 
(30μM, for 30 seconds), capsaicin (100nM for 15 seconds, or 500nM for 30 seconds), 
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mustard oil (50μM for 30 seconds; Sigma) and KCl (50mM for 30 seconds). The 
outlet of the perfusion system was positioned next to the group of neurons from which 
the recordings were obtained. In some experiments, ionomycin (5μM, Sigma) was 
also used as control for maximally increasing the intracellular calcium concentration 
at the end of the recordings. Application of drugs was controlled manually. 
Experiments were performed at 37ºC. Only one field of view was tested on each 
coverslip. 
 
Imaging was performed on either of two systems. Images of Fura-2 loaded cells with 
the excitation wavelength alternating between 340 or 355 and 380nM were captured 
with a Peltier element-cooled slow scan charge-coupled device camera system (PTI, 
NJ, USA or ). Following subtraction of the background fluorescence, the ratio of 
fluorescence intensity at the two wavelengths as a function of time (rate 1Hz) was 
calculated automatically (R = F340/F380 or R = F355/F380) either by the 
ImageMaster 5.0 software package (PTI) or the WinFlour software package (Dr 
Dempster, Strathclyde University, UK). Data were further analysed by the pClamp 10 
software package (Molecular Devices, USA). 
 
Single-cell polymerase chain reaction 
Following whole-cell voltage-clamp recordings, neurons were collected by drawing 
them into large bore electrodes made from borosilicate glass capillaries. Each cell was 
then placed in RT-PCR tubes with 3µl 3.3x RT-PCR buffer, 5µl nuclease free water 
and sonicated for 60s. The 3.3x RT-PCR buffer consisted of 5x First Strand Buffer 
(66µl), 10mM dDNTP Mixture (16.5µl), 3µg/µl Random Primers (4µl) and nuclease 
free water (13µl). One µl DTT (Invitrogen, USA), 0.5µl Superscript II (Invitrogen, 
  26
 
USA) and 0.5µl RNase inhibitor (Promega, USA) were then added to each tube and 
the RNA was reverse transcribed into cDNA at 37oC for 2 hours. cDNA produced 
was then stored at -20oC.  
 
Each cDNA sample was used for 30 cycles of GoTaq DNA polymerase (Promega)-
catalysed PCR with primers designed to amplify the CB1 receptor and GAPDH 
cDNA. The sequences of the primers were as follows: CB1 receptor forward 5’- 
TCCATAGAGAAGGGTATTGATAGAAT -3’ and reverse 5’- 
TTTGTAGCTGTGAGAAGAGGTG -3’ expected size 127 bp, and GAPDH forward 
5’-GGTGAAGGTCGGAGTCAACG-3’ and reverse 5’-
CAAAGTTGTCATGGATGACC-3’, expected size 380 bp. The PCR reaction 
mixture contained cDNA, forward and reverse primers, 1 mM MgCl2, 1× Green Go-
Taq Reaction buffer (Promega), 0.2 mM deoxynucleotide mix (Promega) and 1.25 U 
Go-Taq DNA polymerase (Promega). Each amplification cycle consisted of 
denaturation at 95 oC for 30s, annealing at 57 oC for 60s. PCR products were then 
used as a template for a second round reaction for the CB1 receptor using the same 
primers and conditions. Products were separated on 2% agarose gel by electrophoresis 
and visualized by ethidium bromide. Signals were analyzed with the Syngene 
software. 
 
Combined immunofluorescence staining  
Cultured rat PSN attached to the coverslips were washed with PBS and fixed by 4% 
paraformaldehyde in 0.1 M PBS (pH 7.4) for 10 minutes. Blocking with 10% bovine 
serum albumin was followed by incubating the cells with an anti-TRPV1 (AB5370P, 
Chemicon, raised in rabbit against 21 amino acids of the C terminus 
  27
 
(TGSLKPEDAEVFKDSMVPGEK), diluted at 1:1000) and an anti-CB1 receptor 
(Prof. K. Mackie, raised in goat against 72 amino acids 
(SKDLRHAFRSMFPSCEGTAQPLDNSMGDSDCLHKHANNTASMHRAAESCIK
STVKIAKVTMSVSTDTSAEAL) of the C terminus, diluted at 1:8000; Veress et al., 
2014) antibody overnight, at 4 ºC. Staining was visualised by secondary antibodies 
conjugated with Cyanine 3- and CFTM488A-conjugated secondary antibodies. 
Coverslips were mounted on glass slides with Vectashield containing DAPI (Vector 
Laboratories, UK) and examined using an LSM 510 META confocal laser scanning 
microscope (Zeiss, Oberkochen, Germany). The specificity of the TRPV1 antibody 
were tested on rat DRG sections (Supplementary Figure 12A) and CB1 receptor 
knock out mice 57.  
 
Sodium dodecyl sulfate (SDS)-digested freeze-fracture replica immunolabeling 
Immunohistochemical labeling for electron microscopy was performed as described 
previously (ref). Briefly, adult (150-200g) male Sprague-Dawley rats (n=4) were 
anesthetized with sodium pentobarbital (50mg/kg, i.p.), and perfused transcardially 
with 25 mM phosphate-buffered saline (PBS), followed by 2% paraformaldehyde and 
15% saturated picric acid in 0.1 M phosphate buffer (PB). Sections from DRGs were 
cut at a thickness of 110 μm. The slices were cryoprotected in a solution containing 
30% glycerol in 0.1M PB and then frozen by a high-pressure freezing machine (HPM 
100; Leica, Austria). Frozen samples were inserted into a double replica table and 
fractured into two pieces at -130°C and replicated by carbon deposition (5 nm thick), 
platinum (2 nm), and carbon (15 nm) in a freeze-fracture replica machine (BAF 060; 
BAL-TEC, Lichtenstein). They were digested in a solution containing 2.5% SDS and 
20% sucrose in 15 mM Tris-HCl at 80°C for 18 h then at 60°C for 18 h. The replicas 
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were washed in 25 mM PBS containing 0.05% bovine serum albumin (BSA; Roth, 
Germany) and then incubated in a blocking solution containing 5% BSA for 1 h. 
Subsequently, replicas were incubated in a mixture of primary antibodies (TRPV1 
raised in guinea pig against the 22 amino acids of the C terminus 
(YTGSLKPEDAEVFKDSMVPGEK; Neuromics, USA), the dilution was 1:1000 and 
CB1 receptor (Prof. K. Mackie, raised in goat; Veress et al., 2014), dilution was 
1:4000) in 50 mM Tris-buffered saline (TBS) containing 1% BSA. After several 
washes, replicas were reacted with a mixture of gold-coupled donkey anti-guinea pig 
(for TRPV1; 12 nm) and rabbit anti-goat (for CB1, 5 nm) secondary antibodies (1:30; 
BioCell Research Laboratories, Cardiff, UK) in 25 mM TBS containing 5% BSA. The 
anti-TRPV1 antibody from Neuromics provided better staining in the replicas than 
then the anti-TRPV1 antibody from Chemicon, which we tried in a pilot study. They 
were then washed and picked up on 100-mesh grids. The specificity of the antibodies 
was tested on tissues dissected from TRPV1 and CB1 knock out mice 57, 58.  
 
Immunoprecipitation 
Rat DRGs were homogenized in ice-cold NP40 buffer (Thermo Fisher Scientific, 
Rockford, IL) supplemented with 1 mM PMSF (phenylmethylsulfonyl fluoride; 
Sigma-Aldrich, St. Louis, MO) and protease inhibitor cocktail (Sigma-Aldrich) in a 
HT mini homogenizer (OPS Diagnostics, Lebanon, NJ) using zirconium beads (OPS 
Diagnostics). Homogenates were sonicated twice for 10 sec each and agitated 
constantly for 2 hours at 4°C. Lysates were centrifuged for 20 minutes at 12,000 rpm 
at 4°C. The protein concentration of the supernatant was determined by BCA assay 
(Thermo Fisher Scientific). 
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Immunoprecipitation of 350-500 μg cell lysate was carried out overnight with 2 μg 
rabbit anti-CB1 (H-150; Santa Cruz Biotechnology, Heidelberg, Germany) that was 
raised against the 150 amino acids of the C terminus of the human CB1 receptor 
(MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSF
RGSPFQEKMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIE
CFMVLNPSQQLAIAVLSLTLGTFTVLENLLVLCVILHSRSLRC). The specificity 
of this antibody was studied by Western blotting on brain tissues isolated from CB1 
knock out mice (Supplementary Figure 12B). In another experiment, the 
immunoprecipitation was done by a goat anti-TRPV1 (P-19; Santa Cruz 
Biotechnology) antibody. The specificity of this antibody was shown previously 59. In 
addition we also studied the specificity by Western blotting (Supplementary Figure 
12C).  Samples were constantly agitated at 4°C. Immunoprecipitating antibodies were 
omitted from negative controls (mock control). Antibody/antigen complexes were 
then precipitated with 20 μl protein A/G PLUS agarose (Santa Cruz Biotechnology) 
for 2 h at 4°C. Agarose/antibody complexes were collected by centrifugation at 2500 
rpm for 5 minutes and the pellet was washed four times in ice-cold PBS supplemented 
with 1 mM PMSF and protease inhibitor cocktail. The bound antigen was eluted in 2x 
concentrate dithiothreitol-containing sample buffer by heating to 50°C for 10 min. 
The anti-TRPV1 and anti-CB1 receptor antibodies we used for immunoprecipitation 
provided better signal to noise ration than the antibodies used for immunolabelling.  
 
Immunoprecipitated samples and whole cell lysates (40-60 μg protein; input) were 
analysed on 10% SDS polyacrylamide gel under reducing conditions. Immunoblotting 
was carried out using goat anti-TRPV1 (P-19; Santa Cruz Biotechnology; 1:750) or 
goat anti-CB1 (K-15; Santa Cruz Biotechnology; 1:1000) primary antibodies. 
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Appropriate secondary antibodies were purchased from Santa Cruz Biotechnology. 
Immunoreactive bands were visualised by the SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific) using a Gel Logic 1500 
Imaging System (Kodak, Tokyo, Japan). The specificity of the K-15 anti-CB1 
receptor antibody was assessed by Western blotting using tissues from WT and CB1-
/- mice (Supplementary Figure 12D). 
 
Data analysis and statistics 
Whole-cell recordings were analysed with the ClampFit 8.0 software package. Cells 
were regarded as anandamide- or capsaicin-responsive if the drug application-
associated change in the current exceeded 50pA. 
 
Calcium imaging data were analysed by a custom-made Microsoft Excel macro, 
which following visual inspection of the time-Δratio (340/380 or 355/380) line chart, 
automatically measures the peak amplitude of the calcium transients produced by 
each drug. An increase of more than 10 % in the 340/380(or 355/380) ratio, if it was 
visibly associated with drug application, was regarded as a response. Based on 
previous data (ref), 2.5 times of the standard deviation of the amplitude of the baseline 
noise equals with a maximum of 9.5–10 % increase in the 340/380 (or 355/380) ratio.  
 
Comparison of KCl-evoked increase in the [Ca2+]i in capsaicin-sensitive neurons 
isolated from WT-CB1 and CB1-/- mice revealed that deletion of the CB1 receptor 
significantly reduces the depolarisation-induced changes in the [Ca2+]i (from 
0.73±0.04 (n=122) to 0.48±0.02 (n=112), p<0.0001, Student’s t-test). Therefore, we 
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compared the absolute values of anandamide- and capsaicin-induced changes in 
[Ca2+]i in all calcium imaging experiments. 
 
Electron microscopic morphometric data were analysed by PCA followed by PLS-
DA. PCA is an unsupervised multivariate statistical tool which transforms a large 
number of variables into a smaller number of uncorrelated variables known as PCs. 
PCA generates clusters the separation of which is enhanced by PLS-DA. PLS-DA 
itself is a supervised classification tool which rotates PCA component to achieve the 
largest separation. PLS-DA also provides the information on the variables which 
contribute the most to the separation.     
 
The normality of data was checked by the Kolgomorov-Smirnov test. To find out 
whether cells, based on Manders co-efficient, form more than one group, hierarchical 
cluster analysis was employed. Data obtained by the same drug application were 
averaged. The effects of various treatments were compared with paired or unpaired 
one-tailed or two-tailed Student’s t-test, analysis of variances (ANOVA) followed by 
Fisher’s post-hoc test, or by two-sided Fisher’s exact test as appropriate. Differences 
were regarded significant at p<0.05. In Results, the exact p values are given unless it 
is less than 0.0001. In this latter case, p values are indicated as p<0.0001. Data are 
expressed as mean ± standard error of mean; “n” refers to the number of cells or 
cultures used in the same measurements as indicated.  
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Figure legends 
Figure 1 
Anandamide- and capsaicin-evoked responses are partially segregated in 
cultured primary sensory neurons.  
(A) A typical response to anandamide (10µM) recorded from cultured rat PSN by 
conventional whole-cell voltage-clamp. A sub-population of cells responds to 
anandamide. The response is washed off within a few tens of seconds after stopping 
anandamide application, which is indicated by the bar above the current trace. 
 
(B) Concentration-response relationship of anandamide in cultured rat PSN (data were 
fitted with Hill’s equation: y=Vmax*x^n/(k^n+x^n)). The calculated EC50 is 2.2µM; 
the maximal effect was reached at 30 µM.  
 
(C-D) A typical whole-cell current from a cultured rat PSN during anandamide (bar, 
30µM) application. Capsaicin-evoked response from the same neuron (D). Bar 
indicates capsaicin (500nM) application. A group of cultured PSN, which are 
regarded as “anandamide- and capsaicin-responsive” (ACR) neurons, exhibits this 
response pattern.  
 
(E-F) About a third of the rat PSNs are capsaicin-only-responsive neurons (COR). 
Typical whole-cell voltage-clamp recording from a COR neuron, which fails to 
respond to anandamide (E; bar, 30µM) but exhibits a response to 500nM capsaicin 
(F). Bar indicates capsaicin application. 
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(G) Changes in the intracellular Ca2+ concentrations were measured by a conventional 
ratiometric approach in cultured PSN isolated from wild type (WT) or TRPV1 knock 
out (TRPV1-/-) mice following the application of 30µM anandamide (ANA), 500nM 
capsaicin (CAP), 30µM mustard oil (MO), 50mM KCl and 5µM ionomycin (ION). A 
typical recording of Ca2+ transients from a PSN which is isolated from a WT mouse 
and responds to both anandamide and capsaicin.  
 
(H) A typical recording of Ca2+ transients from a neuron which is isolated from a WT 
mouse and responds to capsaicin but not to anandamide.  
 
(I) Cells isolated from TRPV1-/- mice do not respond to either anandamide or 
capsaicin, however a sub-population of these neurons responds to mustard oil.  
 
Figure 2 
Rimonabant reduces the amplitude of anandamide- and capsaicin-evoked 
currents only in ACR neurons without affecting the ratio of ACR and COR cells.  
(A) Whole-cell currents evoked by 30µM anandamide and subsequent 500nM 
capsaicin applications were also recorded when 200nM rimonabant (Rimo), a highly 
selective and specific antagonist/inverse agonist of the CB1 receptor was continuously 
applied to the cells through the bath solution in order to find the effect of the CB1 
receptor on anandamide- and capsaicin-evoked responses in ACR and COR neurons. 
The presence of rimonabant in the bath solution does not change the ratio of ACR and 
COR neurons (p=1, Fisher’s exact test).  
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(B) Average maximum amplitudes of anandamide-evoked currents produced by 
cultured rat PSN in the control medium and in the presence of 200nM rimonabant 
(Rimo). Rimonabant significantly reduces the amplitude of anandamide-evoked 
currents (p=0.006, Student’s t-test).  
 
(C) Average maximum amplitudes of capsaicin-evoked currents produced by ACR 
and COR type cultured rat PSN in control medium and in the presence of 200nM 
rimonabant (Rimo). The average maximum amplitude of the capsaicin-evoked 
currents in COR type neurons is significantly smaller ($p=0.002, Student’s t-test) than 
that in ACR type neurons in the control bath solution. While the presence of 
rimonabant significantly reduces the average maximum amplitude of capsaicin-
evoked currents in ACR neurons (*p=0.001, Student’s t-test), it has no significant 
effect on the average maximum amplitude of capsaicin-evoked currents in COR 
neurons (p=0.34, Student’s t-test).  
 
Figure 3  
Deletion of the CB1 receptor reduces both anandamide- and capsaicin-evoked 
responses in ACR neurons and changes the ACR – COR ratio.  
(A) Conventional ratiometric approach was used to find the effect of deleting the CB1 
receptor in Biozzi ABH mice on anandamide- and capsaicin-evoked calcium 
transients in ACR and COR type cultured PSN. The ratio of ACR and COR neurons 
in cultures prepared from wild type (WT-CB1) and CB1 receptor knock out (CB1-/-) 
mice. Deletion of the CB1 receptor significantly reduces the number of ACR neurons 
(p<0.0001, Fisher’s exact test), whereas it significantly increases the number of COR 
neurons (p<0.0001, Fisher’s exact test). The overall number of capsaicin-sensitive 
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cells (ACR+COR) however is not changed significantly (p=0.56, Fischer’s exact test, 
see Results). 
 
(B) Average amplitudes of anandamide-evoked calcium transients in ACR neurons 
collected from wild type (WT-CB1) and CB1 receptor knock out (CB1-/-) mice. 
Deletion of the CB1 receptor results in a significant reduction in anandamide-evoked 
calcium transients (p=0.02, Student’s t-test).  
 
(C) Average amplitudes of capsaicin-evoked calcium transients in ACR and COR 
neurons collected from wild type (WT-CB1) and CB1 receptor knock out (CB1-/-) 
mice. Deletion of the CB1 receptor results in significantly reduced amplitude of 
capsaicin-evoked calcium transients in ACR (p=0.01, Student’s t-test) but not in COR 
neurons (p=0.42, Student’s t-test).     
 
Figure 4 
Capsaicin-evoked Ca2+ transients are significantly reduced by rimonabant in 
ACR but not in COR cultured rat PSN.  
(A) Conventional ratiometric approach was used to find the effect of the CB1 receptor 
antagonist/inverse agonist rimonabant (200nM; RIMO) on capsaicin-evoked calcium 
transients in cultured rat PSN. (A) 100nM capsaicin (CAP) was applied in every 2 
minutes followed by 30µM anandamide (A) and 50mM KCl. The recording shows 
calcium transients evoked by consecutive capsaicin application in an ACR type 
neuron in a control experiment when no rimonabant was applied. Capsaicin induces 
the typical desensitisation.  
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(B) During the recording from another ACR type neuron, rimonabant (RIMO) was 
applied immediately after the first capsaicin application until the end of the second 
capsaicin application. Rimonabant reduces the amplitude of the Ca2+ transient evoked 
by the second capsaicin application (arrow). In this neuron, the capsaicin-evoked 
response exhibits partial recovery following the removal of rimonabant.  
 
(C) Average amplitudes of calcium transients evoked by consecutive application of 
100nM capsaicin in every 2 minutes in ACR type neurons either without (C; black 
bars) or with the application of 200nM rimonabant (R; red bars). In control 
experiments capsaicin induces significant desensitisation (*p<0.0001, Student’s t-test 
both for the second and third responses). Rimonabant produces a significant reduction 
in the amplitude of the calcium transients evoked by the second ($p=0.0001, Student’s 
t-test) and third capsaicin ($p<0.0001, Student’s t-test) applications.  
 
(D) Calcium transients evoked by consecutive capsaicin application in a COR type 
neuron (note the lack of response to anandamide).  
 
(E) Rimonabant (RIMO) has no effect on the amplitude of the Ca2+ transient evoked 
by the second capsaicin application in a COR neuron.  
 
(F) Average amplitudes of calcium transients evoked by consecutive application of 
100nM capsaicin in every 2 minutes in COR type neurons either without (C; black 
bars) or with the application of 200nM rimonabant (R; red bars). In control 
experiments capsaicin induced desensitisation (*p<0.0001, Student’s t-test). 
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Rimonabant does not produce any significant change in the amplitude of the calcium 
transients evoked by the capsaicin applications. 
 
Figure 5 
The CB1 receptor is expressed by all ACR type and the majority of COR type 
cultured rat cultured PSN.  
(A) After determining the types of cultured rat PSN by whole-cell voltage-clamp 
recordings by anandamide (30µM) and capsaicin (500nM) application, 76 cells were 
collected for single-cell PCR. 10 COR type, 11 ACR type and 8 “anandamide- and 
capsaicin non-responding” neurons (NR) were successfully processed to find out 
whether the neuron expressed the CB1 receptor. The sizes of the amplicons generated 
to specific primers for CB1 receptor (127 bp) or the house-keeping molecule GAPDH 
(380 bp) were indistinguishable from the predicted sizes as it is shown by these 
typical gel images. L indicates the size marker. Note the presence of the GAPDH and 
the lack of CB1 amplicon in a COR neuron.  
 
(B) All the ACR cells and 8 of 10 COR neurons express the CB1 receptor in this 
sample of neurons. In addition 50% of the non-responding cells also express the CB1 
receptor.   
 
Figure 6 
The SDS-FRL method reveals two major types of CB1 receptor and TRPV1 
spatial distribution in DRG neurons. 
(A, B) Double immunogold labelling for TRPV1 (12 nm particles; arrows) and the 
CB1 receptor (5 nm; arrowheads) reveals that the immunoreactivity for both proteins 
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is moderate (A) to strong (B) on the protoplasmic face (P-face) but not on the 
exoplasmic face (E-face) of plasma membrane of PSN. In some patches of putative 
somatic membrane of PSN, the great majority of immunoparticles for TRPV1 and 
CB1 are isolated from each other (A), whereas on other patches of the membrane 
immunoparticles for TRPV1 and CB1 form co-clusters (arrow+arrowhead in B). Note 
the occasional co-clustering of particles labelling TRPV1 (double arrows in B). 
Scale bars=0.2 μm. 
 
Figure 7 
Morphometric analysis of electron microscopic images reveals three types of 
neurons. 
(A) Based on results of the multivariate statistical tool principal component analysis 
(PCA; see Supplementary Figure 11) we built a partial least square discriminant 
analysis (PLS-DA) model to find classify the groups found by PCA. PLS-DA 
identified three principal components which together accounted for ~80% of the 
variability of data.  
 
(B) The PLS-DA score plot reveals the presence of well-separated three groups of 
neurons.  
 
(C) The loading plot shows the contribution of the variables to the separation of the 
three groups.  
 
(D) The variable importance on projection plot shows that all variables contributed 
significantly to the separation of the groups. The contribution of TRPV1-CB1 average 
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distance (TR-CB dist), TRPV1 density (TR dens) and CB1 receptor density (CB dens) 
is highly significant. TR-CB crit: number of TRPV1-CB receptor critical distances; 
TR-TR crit: number of TRPV1-TRPV1 critical distances; TR-TR dist: TRPV1-
TRPV1 average distance; CB-TR dist: CB1 receptor-TRPV1 average distance. 
 
(E and F) Bar charts showing average values of morphometric data of neurons 
belonging to the three groups shown in (B). Statistical analysis (ANOVA followed by 
Fischer’s post-hoc test) shows that neurons is Group 1 (yellow) are different from 
neurons both in Group 2 (red) and 3 (purple) in CB1 receptor density (CB dens), 
TRPV1 – CB1 receptor average distances (TR-CB dist) and the number of TRPV1 – 
CB1 receptor critical distances (TR-CB crit). Neurons in Group 2 (red) are different 
from neurons in Group 3 (purple) mainly in the distribution of TRPV1 (TRPV1 
density (TR dens); TRPV1-TRPV1 average distance (TR-TR dist) and the number of 
TRPV-TRPV1 critical distance (TR-TR crit)). CB1 receptor-TRPV1 average 
distances (CB-TR dist) are also different between neurons in Group 2 and 3.  
distribution. The number of CB1 receptor TRPV1 critical distances (CB-TR crit) is 
not different between the 3 groups. 
 
Figure 8 
TRPV1 and the CB1 receptor are engaged in PSN. 
Immunoblots showing TRPV1/CB1 receptor heteromers in the rat DRG. Whole cell 
lysates were prepared from DRG and immunoprecipitation assays using anti-CB1 (A) 
and anti-TRPV1 (B) antibodies were carried out as detailed in Materials and Methods. 
The resulting immune complexes were analysed by immunoblotting using anti-
TRPV1 (A) and anti-CB1 (B) antibodies. Immunoprecipitating antibodies and 
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immunoblotting antibodies were omitted from positive and negative controls, 
respectively. TRPV1 was detected as a ~100 kDa band, while the CB1 receptor was 
detected as a doublet with molecular weight ~55 and ~63 kDa in the 
immunoprecipitated samples. 
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Table 1 
Number of cells found in different categories in various experiments. Significance values refer to the 
results of Fischer’s exact p value. Bold indicates significant difference.  
 
Electrophysiology/Ca2+ imaging 
Number of 
experiment 
Description of 
experiment 
Total number of 
capsaicin-
responding 
neurons 
Number of 
ACR neurons 
Number of 
COR neurons 
Significant 
difference  
1 Whole-cell 
recordings from rat 
cultured PSN in 
control bath 
solution 
39 29 10 From No 2: 
p=0.82 
From No 3: 
p=0.65 
From No 5: 
p=0.1 
From No 6: 
p=0.36 
From No 7: 
p=0.009 
From No 9: 
p=0.28 
From No 10: 
p=0.4 
From No 11: 
p=1 
From No 12: 
p=0.08 
From No 15: 
p=1 
2 Ca2+ imaging on 
rat PSN cultures 
57 40 17 From No 1: 
p=0.82 
From No 3: p=1 
From No 9: 
p=0.07 
From No 10: 
p=0.11 
3 Ca2+ imaging in 
WT-TRPV1 mouse 
PSN cultures 
54 37 17 From No 1 
p=0.65 
From No 2: p=1 
4 Ca2+ imaging in 
TRPV1-/- mouse 
0 n/a n/a n/a 
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PSN cultures 
5 Whole-cell 
recordings from 
IB4+ and IB4- cells 
25 13 12 From No 1: 
p=0.1 
From No 6: 0.76 
From No 12: 
p=0.8 
6 Whole-cell 
recordings from rat 
cultured PSN in the 
presence of 
rimonabant 
18 11 7 From No 1: 
p=0.36 
From No 5: 
p=0.76 
From No 12: 
p=0.79 
7 Ca2+ imaging in 
WT-CB1 mouse 
PSN cultures 
124 113 11 From No 1: 
p=0.009 
From No 2: 
p=0.0005 
From No 3: 
p=0.016 
8 Ca2+ imaging in 
CB1-/- mouse PSN 
cultures 
115 74 41 From No 7: 
p<0.0001 
9 Ca2+ imaging in rat 
PSN cultures with a 
priori capsaicin 
application 
197 161 36 From No 1: 
p=0.28 
From No 2: 
p=0.07  
From No 10: 
p=0.71 
10 Ca2+ imaging in rat 
PSN cultures with a 
priori capsaicin 
application and 
rimonabant 
application 
237 190 47 From No 1: 
p=0.4 
From No 2: 
p=0.11 
From No 9: 
p=0.71 
 
11 Ca2+ imaging in rat 
PSN cultures with a 
priori capsaicin 
application and 
1μM NESS0237 
application 
34 25 9 From No 1: p=1 
From No 2: 
p=0.81 
From No 9: 
p=0.35 
12 Whole-cell 
recordings from rat 
56 31 25 From No 1: 
p=0.08 
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cultured PSN for 
single cell PCR 
 From No 5: 
p=0.8 
From No 12: 
p=0.79 
Single-cell polymerase chain reaction 
Number of 
experiment 
Description of 
experiment 
CB1 receptor 
expression in 
ACR neurons 
CB1 receptor 
expression in 
COR neurons 
CB1 receptor 
expression in 
NR neurons 
Significant 
difference 
13 Single-cell PCR 
using RNA from rat 
cultured PSN 
11/11 8/10 4/8 n/a 
Immunofluorescent staining 
Number of 
experiment 
Description of 
experiment 
Total number of 
TRPV1-
expressing cells 
Number of TRPV1 and CB1 
receptor expressing cells 
Significant 
difference 
14 Immunofluorescent 
staining 
150 149 From number of 
capsaicin-
responsive / 
CB1 mRNA 
expressing cells 
in No 12: 
p=0.87 
Electron microcopy 
Number of 
experiment 
Description of 
experiment 
Total number of 
membrane 
patches analysed 
Number of 
patches with 
high/medium 
receptor 
density 
Number of 
patches with 
low receptor 
density 
Significant 
difference from 
ACR/COR ratio 
15 Immuno- electron 
microcopy 
18 14 4 From No 1: p=1 
From No 2: 
p=0.76 
From No 9: 
p=0.75 
From No 12: 
p=0.1 
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Table 2 
Morphometric data of primary sensory neurons examined with SSD-FRL electron microscopy 
 
No of 
membrane 
patch 
Number 
of CB1 
receptors 
Number 
of TRPV1 
Area of 
membrane 
patch (μm2) 
TRPV1-
CB1 
average 
distance 
(nm) 
CB1-
TRPV1 
average 
distance 
(nm) 
TRPV1-
TRPV1 
average 
distance 
(nm) 
Number 
of 
TRPV1-
CB1 
critical 
distances 
Number 
of CB1-
TRPV1 
critical 
distances 
Number 
of 
TRPV1-
TRPV1 
critical 
distances 
1 10 14 1.8 202.9 152.7 199.9 0 0 5 
2 5 8 1.3 305.5 215 276 1 1 1 
3 152 97 6.2 95.7 127.4 85.7 24 29 32 
4 121 83 4 83.8 125.1 80.9 25 25 21 
5 27 28 4.8 222.8 231.8 247.2 1 0 5 
6 96 27 5.6 130.2 169.6 174.9 7 26 5 
7 35 21 4.6 189.5 259.8 179.8 2 14 7 
8 62 83 4.5 164 109.7 116 6 14 28 
9 16 16 5.9 317.6 399.4 308.4 0 0 3 
10 40 38 3 160.7 141.4 93.1 8 10 16 
11 116 109 6.9 126.3 142.5 95.5 16 17 33 
12 74 64 5.6 146 172.5 126.9 10 8 11 
13 357 104 6.4 57.1 93.6 126.8 57 108 19 
14 85 52 5 138.5 230 177.5 15 10 7 
15 79 21 4.5 82.6 159.6 340.1 8 16 0 
16 67 47 7.8 162.6 185.2 135.3 15 15 11 
17 85 41 7.5 172.4 192.9 243.7 5 13 4 
18 95 52 7.9 152.1 206.9 176.4 16 18 9 
19 75 21 3.9 105 238.2 273.2 8 16 3 
20 77 33 5.3 154.1 220.4 235.7 10 12 6 
21 119 36 1.8 87 228.6 204 10 11 6 
 
 








